Website home pages, table of content graphics and graphical abstracts. From assistant professors to biotechs, most everyone at some point needs something eye-catching to sum up their work. You can see here that the artistic style is really customized to the project. 

This was a TOC graphic for the following paper: Tolerance of base pair size and shape in postlesion DNA synthesis. Gahlon HL, Schweizer WB, Sturla SJ. J Am Chem Soc. 2013 May 1;135(17):6384-7

This was a TOC graphic for the following paper:

Tolerance of base pair size and shape in postlesion DNA synthesis. Gahlon HL, Schweizer WB, Sturla SJ. J Am Chem Soc. 2013 May 1;135(17):6384-7

The Nomura Lab at UC Berkeley opened for business in 2011 with this illustration on their website to highlight their work on metabolic pathways and how perturbations at specific sites can cause all sorts of problems for us. 

The Nomura Lab at UC Berkeley opened for business in 2011 with this illustration on their website to highlight their work on metabolic pathways and how perturbations at specific sites can cause all sorts of problems for us. 

The Streiter Lab at the University of Wisconsin, Madison was looking to add some graphic art to their homepage. They study the mechanisms whereby proteins get tagged for destruction.

The Streiter Lab at the University of Wisconsin, Madison was looking to add some graphic art to their homepage. They study the mechanisms whereby proteins get tagged for destruction.

This image was made for a biotech company whose strategy of linking up growth factors led to a velcro-like multivalent effect that increased the output they sought. 

This image was made for a biotech company whose strategy of linking up growth factors led to a velcro-like multivalent effect that increased the output they sought. 

These are buttons I designed for Minerva Biotechnologies' website. Their platforms include cancer therapeutics, gold nanoparticles, and stem cell reagents.

These are buttons I designed for Minerva Biotechnologies' website. Their platforms include cancer therapeutics, gold nanoparticles, and stem cell reagents.

This image details Minerva's gold nanoparticle technology.

This image details Minerva's gold nanoparticle technology.

Click on an image below to explore another portfolio page.